Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1451431
PUBLISHER: IMARC | PRODUCT CODE: 1451431
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032
PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global drug-eluting stents market size reached US$ 8.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.51% during 2024-2032.
A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.
Drug-Eluting Stents Market Trends:
The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.
Breakup by Coating:
Polymer Based Coating
Polymer Free Coating
Breakup by Drug:
Sirolimus
Paclitaxel
Zotarolimus
Everolimus
Biolimus
Others
Breakup by Stent Platform:
Stainless-steel
Cobalt-Chromium
Platinum-Chromium
Nitinol
Others
Breakup by Generation:
1st Generation
2nd Generation
3rd Generation
4th Generation
Breakup by Application:
Coronary Artery Disease
Peripheral Artery Disease
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.
Key Questions Answered in This Report
- 1. What was the size of the global drug-eluting stents market in 2023?
- 2. What is the expected growth rate of the global drug-eluting stents market during 2024-2032?
- 3. What are the key factors driving the global drug-eluting stents market?
- 4. What has been the impact of COVID-19 on the global drug-eluting stents market?
- 5. What is the breakup of the global drug-eluting stents market based on the coating?
- 6. What is the breakup of the global drug-eluting stents market based on the stent platform?
- 7. What is the breakup of the global drug-eluting stents market based on the application?
- 8. What is the breakup of the global drug-eluting stents market based on the end user?
- 9. What are the key regions in the global drug-eluting stents market?
- 10. Who are the key players/companies in the global drug-eluting stents market?
Product Code: SR112024A4815
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Drug-Eluting Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Coating
- 6.1 Polymer Based Coating
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Polymer Free Coating
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug
- 7.1 Sirolimus
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Paclitaxel
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Zotarolimus
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Everolimus
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Biolimus
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Stent Platform
- 8.1 Stainless-steel
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Cobalt-Chromium
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Platinum-Chromium
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Nitinol
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Generation
- 9.1 1st Generation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 2nd Generation
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 3rd Generation
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 4th Generation
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Application
- 10.1 Coronary Artery Disease
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Peripheral Artery Disease
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
11 Market Breakup by End User
- 11.1 Hospitals
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Ambulatory Surgical Centers
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 United States
- 12.1.1.1 Market Trends
- 12.1.1.2 Market Forecast
- 12.1.2 Canada
- 12.1.2.1 Market Trends
- 12.1.2.2 Market Forecast
- 12.1.1 United States
- 12.2 Asia-Pacific
- 12.2.1 China
- 12.2.1.1 Market Trends
- 12.2.1.2 Market Forecast
- 12.2.2 Japan
- 12.2.2.1 Market Trends
- 12.2.2.2 Market Forecast
- 12.2.3 India
- 12.2.3.1 Market Trends
- 12.2.3.2 Market Forecast
- 12.2.4 South Korea
- 12.2.4.1 Market Trends
- 12.2.4.2 Market Forecast
- 12.2.5 Australia
- 12.2.5.1 Market Trends
- 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
- 12.2.6.1 Market Trends
- 12.2.6.2 Market Forecast
- 12.2.7 Others
- 12.2.7.1 Market Trends
- 12.2.7.2 Market Forecast
- 12.2.1 China
- 12.3 Europe
- 12.3.1 Germany
- 12.3.1.1 Market Trends
- 12.3.1.2 Market Forecast
- 12.3.2 France
- 12.3.2.1 Market Trends
- 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
- 12.3.3.1 Market Trends
- 12.3.3.2 Market Forecast
- 12.3.4 Italy
- 12.3.4.1 Market Trends
- 12.3.4.2 Market Forecast
- 12.3.5 Spain
- 12.3.5.1 Market Trends
- 12.3.5.2 Market Forecast
- 12.3.6 Russia
- 12.3.6.1 Market Trends
- 12.3.6.2 Market Forecast
- 12.3.7 Others
- 12.3.7.1 Market Trends
- 12.3.7.2 Market Forecast
- 12.3.1 Germany
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.1.1 Market Trends
- 12.4.1.2 Market Forecast
- 12.4.2 Mexico
- 12.4.2.1 Market Trends
- 12.4.2.2 Market Forecast
- 12.4.3 Others
- 12.4.3.1 Market Trends
- 12.4.3.2 Market Forecast
- 12.4.1 Brazil
- 12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast
13 SWOT Analysis
- 13.1 Overview
- 13.2 Strengths
- 13.3 Weaknesses
- 13.4 Opportunities
- 13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
- 17.3.1.1 Company Overview
- 17.3.1.2 Product Portfolio
- 17.3.1.3 Financials
- 17.3.1.4 SWOT Analysis
- 17.3.2 B. Braun Melsungen AG
- 17.3.2.1 Company Overview
- 17.3.2.2 Product Portfolio
- 17.3.2.3 SWOT Analysis
- 17.3.3 Biosensors International Group Ltd.
- 17.3.3.1 Company Overview
- 17.3.3.2 Product Portfolio
- 17.3.4 Biotronik
- 17.3.4.1 Company Overview
- 17.3.4.2 Product Portfolio
- 17.3.4.3 SWOT Analysis
- 17.3.5 Boston Scientific Corporation
- 17.3.5.1 Company Overview
- 17.3.5.2 Product Portfolio
- 17.3.5.3 Financials
- 17.3.5.4 SWOT Analysis
- 17.3.6 Cardinal Health Inc.
- 17.3.6.1 Company Overview
- 17.3.6.2 Product Portfolio
- 17.3.6.3 Financials
- 17.3.6.4 SWOT Analysis
- 17.3.7 Cook Medical LLC (Cook Group Incorporated)
- 17.3.7.1 Company Overview
- 17.3.7.2 Product Portfolio
- 17.3.7.3 SWOT Analysis
- 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
- 17.3.8.1 Company Overview
- 17.3.8.2 Product Portfolio
- 17.3.8.3 Financials
- 17.3.9 Medtronic plc
- 17.3.9.1 Company Overview
- 17.3.9.2 Product Portfolio
- 17.3.9.3 Financials
- 17.3.9.4 SWOT Analysis
- 17.3.10 MicroPort Scientific Corporation
- 17.3.10.1 Company Overview
- 17.3.10.2 Product Portfolio
- 17.3.11 Sino Medical Sciences Technology Inc.
- 17.3.11.1 Company Overview
- 17.3.11.2 Product Portfolio
- 17.3.12 Terumo Corporation
- 17.3.12.1 Company Overview
- 17.3.12.2 Product Portfolio
- 17.3.12.3 Financials
- 17.3.12.4 SWOT Analysis
- 17.3.1 Abbott Laboratories
Product Code: SR112024A4815
List of Figures
- Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
- Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2023
- Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2023
- Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2023
- Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2023
- Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2023
- Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2023
- Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2023
- Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2023
- Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
- Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
- Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2024-2032
- Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2024-2032
- Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2024-2032
- Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2024-2032
- Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
- Table 10: Global: Drug-Eluting Stents Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.